Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMelanomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

I have stage 4 melanoma which has metastasized. Have dealt with this since 2015 with some years after Keytruda of doing well but Opdualag and melanoma dealing a challenge.

May 1, 2024
 · 
Reactions
MyMelanomaTeam

Yes, pruritus, which includes symptoms like itching, is a common side effect of the immunotherapy drug Opdualag (Nivolumab and Relatlimab-Rmbw). This medication can cause various skin-related issues, including rash and itching, as part of its side effects profile. If you are experiencing severe symptoms like burning or Show Full Answer

Yes, pruritus, which includes symptoms like itching, is a common side effect of the immunotherapy drug Opdualag (Nivolumab and Relatlimab-Rmbw). This medication can cause various skin-related issues, including rash and itching, as part of its side effects profile. If you are experiencing severe symptoms like burning or stinging, it is important to discuss these with your healthcare provider, as they can offer management strategies or adjust your treatment plan if necessary.

May 1, 2024

Related Questions

View All
A MyMelanomaTeam Member asked a question 💭
Ocala, FL

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In